Celigo Continues to be a Valuable Tool for 3D Immunotherapy Models
Metastatic spreading from solid tumors continues to be one of the greatest challenges facing oncologists and clinicians, often leading to a fatal outcome for many patients.
Webinar on Demand: Advanced In-vitro Cancer Models to Study Tumor Microenvironment
During this webinar we will highlight a variety of assays to study the tumor microenvironment
3D Multicellular Tumor Spheroid (MCTS) Kinetic Propidium Iodide Assay
Kinetically monitor multicellular tumor spheroid (MCTS) growth & Propidium Iodide (PI) dead cell signal on U87MG Glioblastoma over mulitple days
3D multicellular tumor spheroid (MCTS) endpoint viability screening assay
Measure the effects of a panel of drugs on the viability of U87MG Glioblastoma MCTS using calcein AM and Propidium Iodide fluorescent staining
Counting of Patient-Derived IDC Organoids
To image and count whole well populations of organoids in a rapid manner without having to take multiple, time consuming Z-stacked images
3D Multicellular Tumor spheroid Endpoint Apoptosis
Monitor the effects of a panel of drugs on the apoptosis of U87MG Glioblastoma MCTS using Caspase 3/7 and Hoechst fluorescent staining
3D Multicellular Tumor Sphere Invasion Screening
Monitor the effects of a panel of drugs on the invasion of U87MG Glioblastoma MCTS into Basement Membrane Extract (BME) Matrigel
3D Multicellular Tumor Spheroid Growth Inhibition Screening
Using the bright field imaging, the Celigo will rapidly provide multicellular tumor spheroid images and diameters of treated U87MG MCTS
Label-Free Tumor Spheroid Growth Inhibition
Using the bright field imaging, the Celigo will rapidly provide multicellular tumorspheroid images and diameters of treated MCTS in a 96-well plate